Dr. Harvey is actively engaged in research focused on comprehensive weight management and metabolic and bariatric surgery, with a particular interest in optimizing outcomes through personalized, multimodal treatment strategies. His current work explores the integration of pharmacologic therapies, endoscopic interventions, and surgical approaches to improve long-term weight loss and metabolic health.
Earlier in his career, Dr. Harvey contributed to the development of innovative surgical techniques, including single-incision laparoscopic surgery and natural orifice transluminal endoscopic surgery (NOTES) -- both aimed at reducing surgical trauma and improving recovery times.
Dr. Harvey has presented his research at numerous national and international conferences, reflecting his commitment to advancing the field of minimally invasive and bariatric surgery through academic scholarship and clinical innovation.
Education
MA Hons oxon, Oxford University
MD, Royal Free Hospital School of Medicine
Residency, Surgery (General Surgery), St. Luke's-Roosevelt Hospital Center
Fellowship, Surgery, Laparoscopic, Mount Sinai Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Harvey has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Harvey has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.